- Congratulations to the Read Lab on two recent publications and a recent grant:
- Publication in Neuro-Oncology, "Modeling Gliomas with Organoids: Classification, Fidelity, and Guidelines for Translational Neuro-Oncology"
- Review article in Frontiers in Oncology, "Modeling gliomas with organoids: reconstructing the human neural microenvironment for translational neuro-oncology"
- Rally Foundation Grant: Synergizing Innate and Adaptive Immunity for High Grade Glioma Therapy
- Congratulations to the Ivanov lab group on their recent publication in the Journal of Medicinal Chemistry titled, "Non-Catalytic Inhibitors of the p38/MK2 Interface: Repurposing Approved Drugs to Target Neuroinflammation in Alzheimer's Disease.”
-
Dr. Qi Zhang has been awarded a research grant from the BrightFocus Foundation for a project on Alzheimer’s disease, in collaboration with co-investigator Dr. Lian Li. The study aims to enable earlier detection of Alzheimer’s disease using glycosylation-based biomarkers and to open new opportunities for personalized diagnosis and treatment.
-
The Ivanov lab received a DoD CDMRP award for the project, “Repurposing Approved Drugs as First-in-Class Disruptors of the p38/MK2 Complex to Suppress Neuroinflammation in ALS”. Collaborators include: Jie Jiang, PhD, Cell Biology; Jimena Andersen, PhD, Human Genetics; Eric Miller, PhD, Pharmacology and Chemical Biology; and Tyler Beyett, PhD, Pharmacology and Chemical Biology.
-
Kukar Lab Receives New R01 Grant Award, "Determining the therapeutic potential and mechanism of Granulins to treat Batten disease and Frontotemporal Dementia."
-
Hongjie Yuan, MD, PhD, Associate Professor in Pharmacology and Chemical Biology, received a grant, “Genetic Rescue of Synaptic and Behavioral Deficitsin a GRIN2B Truncating Variant Mouse Model,” for 2026 from the GRIN2B Foundation to fund research to promote scientific understanding of the rare genetic condition known as GRIN2B-Related Neurodevelopmental Disorder.
- Congratulations to the Traynelis/Yuan lab team on their recent publication in the Brain titled, "Inhibition of GluN2B-containing N-methyl-D-aspartate receptors by radiprodil.”
- Several faculty from Pharmacology and Chemical Biology were featured in the winter 2026 Emory Winship magazine cover story, "From Bench to Bedside." The article explains how researchers at the Winship Cancer Institute are working to move cancer treatments from laboratory discoveries to real patient care, emphasizing the importance of collaboration across disciplines and continued support for early-stage research to maintain a strong pipeline of new treatments.
-
Xiulei Mo, PhD, and Andrey Ivanov, PhD, were promoted to Associate Professor of Pharmacology and Chemical Biology (effective September 1, 2026).
- Congratulations to Callie Wigington, PhD, Program Director of the Center for New Medicines and BDCI, who was honored with the 2025 Emory SOM Excellence in Innovation Award.
- Lian Li, PhD, Professor and Vice Chair of Pharmacology and Chemical Biology, has been elected to American Society for Pharmacology and Experimental Therapeutics (ASPET).